期刊
TRANSLATIONAL RESEARCH
卷 156, 期 3, 页码 112-129出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.trsl.2010.06.008
关键词
-
Cardiovascular disease is the leading cause of death and disability in the Western world. In addition to the advancement of current therapeutic approaches to reduce the associated morbidity and mortality, regenerative medicine and cell-based therapy have been areas of continuous investigation. Circulating and bone-marrow-derived stem or endothelial progenitor cells are an attractive source for regenerative therapy in the cardiovascular field. In this review, we highlight the advantages and limitations of this approach with a focus on key observations from animal studies and clinical trials. (Translational Research 2010;156:112-129)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据